These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23669283)

  • 1. NKT-cell subsets: promoters and protectors in inflammatory liver disease.
    Kumar V
    J Hepatol; 2013 Sep; 59(3):618-20. PubMed ID: 23669283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
    Swain MG
    Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice.
    Maricic I; Sheng H; Marrero I; Seki E; Kisseleva T; Chaturvedi S; Molle N; Mathews SA; Gao B; Kumar V
    Hepatology; 2015 Apr; 61(4):1357-69. PubMed ID: 25477000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.
    Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM
    Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.
    Torina A; Guggino G; La Manna MP; Sireci G
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
    J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
    Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
    J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different subsets of natural killer T cells may vary in their roles in health and disease.
    Kumar V; Delovitch TL
    Immunology; 2014 Jul; 142(3):321-36. PubMed ID: 24428389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.